Form 8-K - Current report:
SEC Accession No. 0001104659-24-078464
Filing Date
2024-07-09
Accepted
2024-07-09 08:30:21
Documents
15
Period of Report
2024-07-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2419092d1_8k.htm   iXBRL 8-K 30570
2 EXHIBIT 99.1 tm2419092d1_ex99-1.htm EX-99.1 9404
6 GRAPHIC tm2419092d1_ex99-1img001.jpg GRAPHIC 4420
  Complete submission text file 0001104659-24-078464.txt   222590

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20240709.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20240709_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20240709_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2419092d1_8k_htm.xml XML 3559
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 241106398
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)